Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fricker

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Pharmacokinetics of antiviral polyoxometalates in ratsL Ni, F D Boudinot, S G Boudinot, et al.
Innovation (Cambridge (Mass.))|August 15, 2025
A fully automated, ultrasensitive luminescence cascade sensor to address hepatitis C diagnostic disparitySungwan Kim, Adharsh Chellappaa, Juhyeon Chun, et al.
Inorganic Chemistry|March 18, 2003
Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengersBeth R Cameron, Marilyn C Darkes, Helen Yee, et al.
Familial Cancer|February 22, 2012
French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testingC Maheu, T Apostolidis, A Petri-Cal, et al.
Journal of Animal Science|April 16, 2019
The effects of incomplete milking and increased milking frequency on milk production rate and milk composition1Jordan M Kuehnl, Meghan K Connelly, Alen Dzidic, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Plos One|March 7, 2019
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitalsV V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Pharmacokinetics of antiviral polyoxometalates in ratsL Ni, F D Boudinot, S G Boudinot, et al.
Innovation (Cambridge (Mass.))|August 15, 2025
A fully automated, ultrasensitive luminescence cascade sensor to address hepatitis C diagnostic disparitySungwan Kim, Adharsh Chellappaa, Juhyeon Chun, et al.
Inorganic Chemistry|March 18, 2003
Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengersBeth R Cameron, Marilyn C Darkes, Helen Yee, et al.
Familial Cancer|February 22, 2012
French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testingC Maheu, T Apostolidis, A Petri-Cal, et al.
Journal of Animal Science|April 16, 2019
The effects of incomplete milking and increased milking frequency on milk production rate and milk composition1Jordan M Kuehnl, Meghan K Connelly, Alen Dzidic, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Plos One|March 7, 2019
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitalsV V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Pageof 15